Making robust choices: evaluating materials in your AAV process
Michael Bodo, Birgit Rogell
Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach
Alex Lei, Sabrina Carmichael
Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy
Chesney Michels, Claire Guéguen
Targeting brain delivery of lipid and polymer nanoparticle-based gene therapies with Sunshine
B Knappett, N Bhingaradiya, M Dewani
Exploring key regulatory considerations to ensure patient safety in the gene therapy space
L Shaw, C Le Bec, M Orio et al.